Department of Urology, Pusan National University School of Medicine, Yangsan, Korea.
Department of Urology, Pusan National University Hospital, Busan, Korea.
Investig Clin Urol. 2023 Sep;64(5):501-509. doi: 10.4111/icu.20220377.
To investigate the treatment outcome of nocturnal enuresis (NE) according to first-morning urine osmolality (Uosm) before treatment.
Ninety-nine children (mean age, 7.2±2.1 y) with NE were enrolled in this retrospective study and divided into two groups according to first-morning Uosm results, that is, into a low Uosm group (<800 mOsm/L; 38 cases, 38.4%) or a high Uosm group (≥800 mOsm/L; 61 cases, 61.6%). Baseline parameters were obtained from frequency volume charts of at least 2 days, uroflowmetry, post-void residual volume, and a questionnaire for the presence of frequency, urgency, and urinary incontinence. Standard urotherapy and pharmacological treatment were administered initially in all cases. Enuresis frequency and response rates were analyzed at around 1 month and 3 months after treatment initiation.
The level of first-morning Uosm was 997.1±119.6 mOsm/L in high Uosm group and 600.9±155.9 mOsm/L in low Uosm group (p<0.001), and first-morning voided volume (p=0.021) and total voided volume (p=0.019) were significantly greater in the low Uosm group. Furthermore, a significantly higher percentage of children in the low Uosm group had a response rate of ≥50% (CR or PR) at 1 month (50.0% vs. 24.6%; p=0.010) and 3 months (63.2% vs. 36.1%; p=0.009).
Treatment response rates are higher for children with NE with a lower first-morning Uosm.
研究治疗前晨尿渗透压(Uosm)对遗尿症(NE)治疗结果的影响。
本回顾性研究纳入 99 例 NE 患儿(平均年龄 7.2±2.1 岁),根据晨尿 Uosm 结果分为两组,即低 Uosm 组(<800 mOsm/L;38 例,38.4%)或高 Uosm 组(≥800 mOsm/L;61 例,61.6%)。从至少 2 天的频率体积图表、尿流率、残余尿量和存在频率、尿急和尿失禁问卷中获取基线参数。所有患者均接受标准尿路治疗和药物治疗。在治疗开始后约 1 个月和 3 个月分析遗尿频率和反应率。
高 Uosm 组晨尿 Uosm 水平为 997.1±119.6 mOsm/L,低 Uosm 组为 600.9±155.9 mOsm/L(p<0.001),低 Uosm 组晨尿排空量(p=0.021)和总排空量(p=0.019)明显更大。此外,低 Uosm 组在 1 个月(50.0% vs. 24.6%;p=0.010)和 3 个月(63.2% vs. 36.1%;p=0.009)时,具有≥50%反应率(CR 或 PR)的患儿比例明显更高。
治疗前晨尿渗透压较低的 NE 患儿治疗反应率更高。